Compound heterozygous mutations occur in the majority of ARPKD cases (Bergmann et al., 2005; Burgmaier et al., 2021), thus this PKHD1‐mutant line is a valuable model. Here, PKHD1 is linked to autosomal recessive polycystic kidney disease.